These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29061790)

  • 1. Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma.
    Kamata E; Kawamoto T; Ueha T; Hara H; Fukase N; Minoda M; Morishita M; Takemori T; Fujiwara S; Nishida K; Kuroda R; Kurosaka M; Akisue T
    Anticancer Res; 2017 Nov; 37(11):6097-6106. PubMed ID: 29061790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells.
    Langdon CG; Wiedemann N; Held MA; Mamillapalli R; Iyidogan P; Theodosakis N; Platt JT; Levy F; Vuagniaux G; Wang S; Bosenberg MW; Stern DF
    Oncotarget; 2015 Nov; 6(35):37410-25. PubMed ID: 26485762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
    Duo J; Ma Y; Wang G; Han X; Zhang C
    DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis.
    Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
    Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.
    Hu T; Fei Z; Su H; Xie R; Chen L
    Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsed Electromagnetic Field Stimulation Promotes Anti-cell Proliferative Activity in Doxorubicin-treated Mouse Osteosarcoma Cells.
    Muramatsu Y; Matsui T; Deie M; Sato K
    In Vivo; 2017 Jan; 31(1):61-68. PubMed ID: 28064222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synergistic anticancer effect of artesunate combined with allicin in osteosarcoma cell line in vitro and in vivo.
    Jiang W; Huang Y; Wang JP; Yu XY; Zhang LY
    Asian Pac J Cancer Prev; 2013; 14(8):4615-9. PubMed ID: 24083713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.
    Matzinger O; Viertl D; Tsoutsou P; Kadi L; Rigotti S; Zanna C; Wiedemann N; Vozenin MC; Vuagniaux G; Bourhis J
    Radiother Oncol; 2015 Sep; 116(3):495-503. PubMed ID: 26096848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
    Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
    Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apigenin induces apoptosis through mitochondrial dysfunction in U-2 OS human osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth in vivo.
    Lin CC; Chuang YJ; Yu CC; Yang JS; Lu CC; Chiang JH; Lin JP; Tang NY; Huang AC; Chung JG
    J Agric Food Chem; 2012 Nov; 60(45):11395-402. PubMed ID: 23066961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smac mimetics in combination with TRAIL selectively target cancer stem cells in nasopharyngeal carcinoma.
    Wu MS; Wang GF; Zhao ZQ; Liang Y; Wang HB; Wu MY; Min P; Chen LZ; Feng QS; Bei JX; Zeng YX; Yang D
    Mol Cancer Ther; 2013 Sep; 12(9):1728-37. PubMed ID: 23699656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARγ Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model.
    Higuchi T; Yamamoto J; Sugisawa N; Tashiro Y; Nishino H; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
    Cancer Genomics Proteomics; 2020; 17(1):35-40. PubMed ID: 31882549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs.
    Kleinsimon S; Kauczor G; Jaeger S; Eggert A; Seifert G; Delebinski C
    BMC Complement Altern Med; 2017 Jan; 17(1):26. PubMed ID: 28061770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
    Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
    Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro.
    Rathore K; Cekanova M
    Drug Des Devel Ther; 2015; 9():5323-35. PubMed ID: 26451087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
    Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
    Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
    Park KR; Yun HM; Quang TH; Oh H; Lee DS; Auh QS; Kim EC
    Oncotarget; 2016 Feb; 7(6):6960-71. PubMed ID: 26755649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.
    Gonçalves C; Martins-Neves SR; Paiva-Oliveira D; Oliveira VE; Fontes-Ribeiro C; Gomes CM
    Life Sci; 2015 Jun; 130():47-56. PubMed ID: 25818183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2α/ATF4/CHOP axis.
    Xian M; Cao H; Cao J; Shao X; Zhu D; Zhang N; Huang P; Li W; Yang B; Ying M; He Q
    Int J Cancer; 2017 Sep; 141(5):1029-1041. PubMed ID: 28524233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.